HPV Infection study: Q-Pad hrHPV Test System
Official title Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
ClinicalTrials.gov ID: NCT07281599
What this study is testing
- What it's testing
- The study wants to find out if the Q‑Pad kit can accurately spot high‑risk HPV from menstrual blood and how well it works compared to the usual cervical test.
- Who it's for
- People who have been sent for a colposcopy after an abnormal Pap smear or HPV test.
- What's involved
- Participants will use a special pad during their period to collect a sample, mail it to a lab, and also have the regular cervical sample taken as part of their normal care.
- Time commitment
- The study involves one at‑home sample collection and the usual colposcopy visit, with no extra long‑term visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- You are 25 years old or older and have an intact cervix.
- You were referred for a colposcopy after an abnormal Pap or HPV screen.
- Your periods come regularly-about every 21-35 days.
- You own a smartphone, have an email address, and can read the Qvin app instructions in English.
- You are willing to sign the consent form (electronically).
You likely can't join if
- You are pregnant or think you might be.
- You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
- You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
- You have already joined this study or are in another cervical-screening / HPV study right now.
See the full eligibility criteria
- You are 25 years old or older and have an intact cervix.
- You were referred for a colposcopy after an abnormal Pap or HPV screen.
- Your periods come regularly-about every 21-35 days.
- You own a smartphone, have an email address, and can read the Qvin app instructions in English.
- You are willing to sign the consent form (electronically).
- You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.
- You are pregnant or think you might be.
- You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).
- You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.
- You have already joined this study or are in another cervical-screening / HPV study right now.
The study team makes the final eligibility decision.
Where it is enrolling
- New Haven, Connecticut, United States
- Minneapolis, Minnesota, United States
- Akron, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New Haven, Connecticut, United States; Minneapolis, Minnesota, United States; Akron, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.